新结构四联噻吩:5,5'-二[2,5-二(三甲基硅)-3-噻吩]基-2,2'-联噻吩的合成与晶体结构(英文)

一种结构明确的新结构四联噻吩化合物:5,5'-二[2,5-二(三甲基硅)-3-噻吩]基-2,2'-联噻吩(1)被有效合成出来。以2,3'-联噻吩(4)为建筑模块,通过NBS选择性溴代高产率得到5-溴-2,3'-联噻吩(5),进而通过氯化铜氧化偶联有效的合成出1。本文还对目标产物的单晶结构和紫外吸收光谱进行了分析。

基于二噻吩并[2,3-b:3′,2′-d]噻吩开环反应的二芘基四联噻吩的制备及其激基缔合物荧光行为

通过芘基锂对二(三甲基硅基)二噻吩并[2,3-b:3′,2′-d]噻吩开环产生碳负离子,再经氯化铜氧化偶联,获得二芘基四联噻吩化合物.考察了该化合物在溶液中的光谱行为,结果表明,该化合物在溶液相的部分分子可以发生基于分子构象折叠而形成的分子内激基缔合物;在THF-H2O二元体系中可以形成分子间的基于激基缔合物的聚集诱导发光现象.

Synthesis of (3aS,6aR)-1,3-Dibenzyl-tetrahydro-1H- thieno[3,4-d]-imidazole-2(3H)-one-4-ylidenepentanoic Acid and Characterization of Its Crystal

The intermediate of d-biotin, (3aS,6aR)-1,3-dibenzyltetrahydro-1H-thieno[3,4- d]-imidazole-2(3H)-one-4-ylidenepentanoil acid was synthesized from (3aS,6aR)-1,3-dibenzylte- trahyro-4H-thieno[3,4-d]-imidazole-2,4(1H)-dione by using the Grignard reaction. The structure of 3 was characterized by IR, 1H NMR and MS, and the absolute configuration was further confirmed by X-ray crystal structure analysis. Compound 3 crystallizes in monoclinic, space group P21 with a = 11.030(2), b = 7.783(2), c = 12.797(2) , b = 93.44(1)o, Z = 2, Mr = 422.53 (C24H26N2O3S), V = 1096.3(6) 3, = 0.177 mm-1, Dc = 1.280 g/cm3, F(000) = 448 and T = 293(2) K. The final R = 0.0737 and Rw = 0.1974 for 1009 observed reflections with I >2s(I).